Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Lane

Showing results (141-150 of 150) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 150 results.
BMC Plant Biology|March 13, 2014
Reduced polyphenol oxidase gene expression and enzymatic browning in potato (Solanum tuberosum L.) with artificial microRNAsMing Chi, Basdeo Bhagwat, W David Lane, et al.
Plos One|August 23, 2012
Binding of Translationally Controlled Tumour Protein to the N-terminal domain of HDM2 is inhibited by nutlin-3Garth Funston, Walter Goh, Siau Jia Wei, et al.
Skeletal Radiology|August 6, 2010
Combination radiofrequency ablation and cementoplasty for palliative treatment of painful neoplastic bone metastasis: experience with 53 treated lesions in 36 patientsMichael David Lane, Huy B Q Le, Steven Lee, et al.
G3 (Bethesda, Md.)|February 19, 2021
Identification of pathways modulating vemurafenib resistance in melanoma cells via a genome-wide CRISPR/Cas9 screenCorinna Jie Hui Goh, Jin Huei Wong, Chadi El Farran, et al.
G3 (Bethesda, Md.)|February 16, 2022
Correction to: Identification of pathways modulating vemurafenib resistance in melanoma cells via a genome-wide CRISPR/Cas9 screenCorinna Jie Hui Goh, Jin Huei Wong, Chadi El Farran, et al.
Scientific Reports|January 6, 2025
Targeting mutant p53: Evaluation of novel anti-p53<sup>R175H</sup> monoclonal antibodies as diagnostic toolsDiana Spiegelberg, Le-Ann Hwang, Khian Hong Pua, et al.
Journal of Medicinal Chemistry|January 4, 2024
Delivery to, and Reactivation of, the p53 Pathway in Cancer Cells Using a Grafted Cyclotide Conjugated with a Cell-Penetrating PeptideGrégoire Jean-Baptiste Philippe, Yen-Hua Huang, Anna Mittermeier, et al.
Journal of Medicinal Chemistry|March 28, 2020
Optimization of Tetrahydroindazoles as Inhibitors of Human Dihydroorotate Dehydrogenase and Evaluation of Their Activity and In Vitro Metabolic StabilityGergana Popova, Marcus J G W Ladds, Lars Johansson, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 24, 2020
Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cellsSilke Eisinger, Dhifaf Sarhan, Vanessa F Boura, et al.
Mabs|February 28, 2018
When monoclonal antibodies are not monospecific: Hybridomas frequently express additional functional variable regionsAndrew R M Bradbury, Nathan D Trinklein, Holger Thie, et al.
Pageof 15

Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
BMC Plant Biology|March 13, 2014
Reduced polyphenol oxidase gene expression and enzymatic browning in potato (Solanum tuberosum L.) with artificial microRNAsMing Chi, Basdeo Bhagwat, W David Lane, et al.
Plos One|August 23, 2012
Binding of Translationally Controlled Tumour Protein to the N-terminal domain of HDM2 is inhibited by nutlin-3Garth Funston, Walter Goh, Siau Jia Wei, et al.
Skeletal Radiology|August 6, 2010
Combination radiofrequency ablation and cementoplasty for palliative treatment of painful neoplastic bone metastasis: experience with 53 treated lesions in 36 patientsMichael David Lane, Huy B Q Le, Steven Lee, et al.
G3 (Bethesda, Md.)|February 19, 2021
Identification of pathways modulating vemurafenib resistance in melanoma cells via a genome-wide CRISPR/Cas9 screenCorinna Jie Hui Goh, Jin Huei Wong, Chadi El Farran, et al.
G3 (Bethesda, Md.)|February 16, 2022
Correction to: Identification of pathways modulating vemurafenib resistance in melanoma cells via a genome-wide CRISPR/Cas9 screenCorinna Jie Hui Goh, Jin Huei Wong, Chadi El Farran, et al.
Scientific Reports|January 6, 2025
Targeting mutant p53: Evaluation of novel anti-p53<sup>R175H</sup> monoclonal antibodies as diagnostic toolsDiana Spiegelberg, Le-Ann Hwang, Khian Hong Pua, et al.
Journal of Medicinal Chemistry|January 4, 2024
Delivery to, and Reactivation of, the p53 Pathway in Cancer Cells Using a Grafted Cyclotide Conjugated with a Cell-Penetrating PeptideGrégoire Jean-Baptiste Philippe, Yen-Hua Huang, Anna Mittermeier, et al.
Journal of Medicinal Chemistry|March 28, 2020
Optimization of Tetrahydroindazoles as Inhibitors of Human Dihydroorotate Dehydrogenase and Evaluation of Their Activity and In Vitro Metabolic StabilityGergana Popova, Marcus J G W Ladds, Lars Johansson, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 24, 2020
Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cellsSilke Eisinger, Dhifaf Sarhan, Vanessa F Boura, et al.
Mabs|February 28, 2018
When monoclonal antibodies are not monospecific: Hybridomas frequently express additional functional variable regionsAndrew R M Bradbury, Nathan D Trinklein, Holger Thie, et al.
Pageof 15